BRIDGEWATER, N.J., Aug. 4 /PRNewswire-FirstCall/ -- With acne being one of the most common skin diseases affecting nearly 80 percent of people between the ages of 12 and 24, Dermik Laboratories, a business of sanofi-aventis U.S., announced today the availability of the BenzaClin® (clindamycin 1%-benzoyl peroxide 5% gel) carekit, a unique prescribing option for patients with acne who want to add a moisturizing agent to their skin care regimen.
The BenzaClin carekit features the 50g BenzaClin® PUMP packaged with 20 ampoules of Viscontour® Serum, a cosmetic product. Viscontour Serum topical hyaluronic acid offers a simple and convenient way of moisturizing the skin. When applied topically Viscontour acts as a natural moisture reservoir for the skin.
"We are excited about the availability of the BenzaClin carekit because it broadens the landscape of what physicians can offer their patients who are seeking a moisturizing agent while using BenzaClin for their acne," says Brent Ragans, Vice President and Head of the General Therapeutics Business Unit, sanofi-aventis.
While maintaining moisture can be a challenge for teens and young adults dealing with acne, the arrival of the carekit offers an acne treatment and a moisturizer under one easy to write prescription.
In addition to the BenzaClin carekit, patients can choose from a variety of prescribing options including the one-of-a-kind BenzaClin 50g PUMP, which is the flagship of the BenzaClin line of products, as well as the BenzaClin® 25g jar.
BenzaClin is a topical, prescription acne treatment that combines the acne-fighting power of benzoyl peroxide and clindamycin, and has been shown to reduce acne in as little as two weeks. For more information about the BenzaClin carekit and the BenzaClin prescribing family, visit www.BenzaClin.com or for more information about acne please visit www.AcneHeroes.com .
About BenzaClin®
BenzaClin® is proven effective in treating acne, including whiteheads, blackheads, and pimples. In clinical trials, BenzaClin® worked better than either individual components, clindamycin or benzoyl peroxide alone for the topical treatment of acne. With BenzaClin®, improvements have been shown to occur in as early as two weeks.
BenzaClin® is indicated for the topical treatment of acne.
Important Safety Information
BenzaClin® was studied in mild to moderate acne patients. BenzaClin® is an acne product you can get with a doctor's prescription. Side effects are usually limited to the skin and include dry skin, itching, peeling, redness and sunburn. Also, clindamycin, an ingredient in BenzaClin®, may cause diarrhea. If you experience severe diarrhea, stop using BenzaClin® and call your doctor immediately. You should not use BenzaClin® if you are allergic to clindamycin, benzoyl peroxide, or the antibiotic lincomycin, or if you have a history of colitis.
Please see full prescribing information at www.benzaclin.com.
About Viscontour®
Viscontour® Serum is a cosmetic hydration agent that offers you a simple and convenient way of moisturizing your skin. Applied topically, Viscontour® Serum works to help restore and sustain hydration.
About sanofi-aventis
Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the lives of patients. Sanofi-aventis is listed in Paris (Euronext: SAN) and in New York (NYSE: SNY). For more information, www.sanofi-aventis.us or www.sanofi-aventis.com
Contacts
Amy Ba
Tel: 908-981-6563
Mobile: 646-207-4935
Email: amy.ba@sanofi-aventis.com
SOURCE: sanofi-aventis
Web site: http://www.sanofi-aventis.us/
http://www.sanofi-aventis.com/
Company News On-Call: http://www.prnewswire.com/comp/232375.html